Evidence map›Paper›PMID 40753129›Full record

ArticleMedical oncology (Northwood, London, England)2025

Antineoplastic potential of Kushneria avicenniae pigments via modulation of the BAX/BCL-2 axis and CASP-9 pathway in inducing G2/M arrest and apoptosis in liver and breast cancer.

Hoda Almetwaly, Alaa Elmetwalli, Yasser A El-Amier, Ashraf Elsayed

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hoda Almetwaly *Botany Department, Faculty of Science, Mansoura University, Elgomhouria St., Mansoura, 35516, Egypt.
Alaa Elmetwalli *Prince Fahad bin Sultan Research Chair for Biomedical Research, University of Tabuk, Tabuk, Saudi Arabia. aelmetwalli@ut.edu.sa.ORCID http://orcid.org/0000-0001-5372-4297
Yasser A El-AmierBotany Department, Faculty of Science, Mansoura University, Elgomhouria St., Mansoura, 35516, Egypt.
Ashraf ElsayedBotany Department, Faculty of Science, Mansoura University, Elgomhouria St., Mansoura, 35516, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since cancer continues to be a chief cause of disease and mortality worldwide, new and efficient treatment approaches are desperately needed. Natural substances have become a foremost source of bioactive molecules with intriguing cytotoxic effects, particularly those originating from microbes. The cytotoxic potential of pigments derived from the halophilic bacteria Kushneria avicenniae HA346018, which was isolated from mangrove environments, is investigated in this work. These pigments' cytotoxic, apoptotic, and cell cycle-modulating properties were assessed in human HepG2 and MCF-7 cell lines. Both cancer cell lines revealed a dose-dependent decrease in cell viability, indicating the pigment extract's potent cytotoxic effects in vitro. HepG2 and MCF-7 cells have computed IC50 values of 52.7 ± 3.8 µg/mL and 48.3 ± 4.1 µg/mL, respectively. Its notable selective cytotoxicity highlighted the pigment's potential as a targeted therapy, which revealed much less toxicity against normal WI-38 cells. A notable concentration of cells in the G2/M phase and a considerable change in cell cycle progression were seen by flow cytometric analysis, indicating the extract's potential to cause cell cycle arrest. The regulation of cyclin-dependent kinases (CDKs) and DNA damage response pathways was associated with this inhibition at the G2/M checkpoint. Moreover, Annexin V-FITC/PI labeling and subsequent flow cytometric analysis verified that the pigment caused both early and late apoptotic events. The mitochondrial mechanisms that mediated the apoptosis were the elevation of pro-apoptotic proteins like Bax and the downregulation of anti-apoptotic proteins like Bcl-2, which eventually led to caspase activation. These results establish Kushneria avicenniae pigments as a viable source of bioactive chemicals with therapeutic potential for breast and liver malignancies by offering new mechanistic insights into their apoptosis-inducing effect in cancer cell lines. This study encourages more investigation into natural compounds obtained from microorganisms as potential substitutes for traditional cancer therapies.

Indexed as

Antineoplastic AgentsApoptosisbcl-2-Associated X ProteinBreast NeoplasmsCaspase 9G2 Phase Cell Cycle CheckpointsLiver NeoplasmsPigments, BiologicalFemaleHep G2 CellsHumansMCF-7 CellsProto-Oncogene Proteins c-bcl-2Signal TransductionAntineoplastic AgentsBAX protein, humanbcl-2-Associated X ProteinBCL2 protein, humanCASP9 protein, humanCaspase 9Pigments, BiologicalProto-Oncogene Proteins c-bcl-2ApoptosisG2/M checkpointHepG2Kushneria avicenniaeLiver cancer

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.